Pearl BioSystem develops a method to screen chemical libraries in liquid pearls using an animal-free model. The company focuses on drug discovery, toxicology testing, cancer immunotherapy, and stem cell research and development. Their technology includes automation for high-content screening (HCS), immune stimulation, and co-culture workflows. Pearl BioSystem scientists collaborate with clients to develop customized statements of work for various projects.
